The Evolution of Insulin Replacement Therapy: New Perspectives and Clinical Applications Free Diabetes CME
Live online September 14, 2017, October 19, 2017 and November 30, 2017 (2 sessions) and available on demand through May 30, 2018.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...4.0. 
CME Credits Awarded by....Joslin Diabetes Center.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based primary care providers, clinical endocrinologists/diabetologists, nephrologists, cardiologists, emergency department specialists, pharmacists, and other clinicians caring for patients with type 2 diabetes mellitus (T2DM).
Educational material updated....September 14, 2017.
Expiration of CME credit...May 30, 2018.
Financial Support...Novo Nordisk Inc. and Medtronic, Inc.
The Evolution of Insulin Replacement Therapy consists of 4 presentations with discussion:
• Session 1: Insulin Options for Diabetes: Update on their Evolution
• Session 2: Advancing to Insulin Therapy for Type 2 Diabetes: The Impact of the New Insulin Options
• Session 3: Physiologic Insulin Replacement: Practical Approaches for the Primary Care Provider
• Session 4: The Evolution of Glycemic Monitoring and Insulin Delivery Devices: Why the Primary Care Provider Should Understand the Options
At the conclusion of The Evolution of Insulin Replacement Therapy, you will be able to:
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Discuss the clinical importance of similarities and differences between a biosimilar insulin and a reference insulin
• Recognize the indications for advancement to insulin replacement therapy for people with T2DM
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Describe initiation and titration methods for new insulin-based therapies to optimize achievement of glycemic goals while minimizing adverse effects
• Discuss strategies to overcome patient and clinician barriers to the successful initiation and utilization of insulin therapy in the context of the new insulin-based therapies, and monitoring and delivery devices

The Newest in Non-Small Cell Lung Cancer (NSCLC): Emerging Therapies, Novel Approaches, Therapeutic Updates, and Barriers to Care and Incorporating Best Practice Lung Cancer CME
Posted by...Bernard Sklar, MD.  
Oncology CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Instruction Type...Slide-Video Lectures.
Format...Online Video.
Target Audience...Healthcare professionals specializing in: interventional radiology; nuclear medicine; oncology; palliative care; pathology; pulmonology; or those who otherwise commonly care for patients with NSCLC.
Educational material last updated....May 9, 2016
Expiration of CME credit...May 9, 2018.
Financial Support...Boehringer Ingelheim.
The Newest in Non-Small Cell Lung Cancer (NSCLC) has been designed to bring your knowledge of the rationale behind treatment of NSCLC up to date and to enhance your competence in caring for patients with NSCLC. 
After viewing The Newest in Non-Small Cell Lung Cancer (NSCLC), you will be better able to:
• Describe the impact of biomarker and mutation testing and their results for the management of patients with NSCLC and apply this knowledge to patient cases.
• Describe the role and impact of the initial biopsy, including the relevance of its timing and factors affecting quality of results.
• Distinguish between different NSCLC disease subtypes on the basis of histology, biomarker, and mutation status and use the information to optimize care in the setting of patient cases.
• Discuss the ways that NSCLC has proved resistant to treatments in past and the mechanisms of action of targeted therapies, present and emerging.
In order to get credit from ScientiaCME, you must first establish a username and password.